BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Gastrointestinal Pharmacology and Therapeutics

The World Journal of Gastrointestinal Pharmacology and Therapeutics (WJGPT) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal pharmacology and therapeutics.  It was launched on February 6, 2010 and is published trimonthly (4 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage pharmacology and therapeutics specialists worldwide to submit manuscripts to the WJGPT describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJGPT are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJGPT’s acceptance rate: 49%.  Submit here >>

2016 Published Issues
4 3 2 1
Editors-in-Chief

Hugh Freeman, FACG, FACP, FRCP(C), MD, Professor

Indexing/Abstracting

PubMed, PubMed Central.

Journal Metrics

There is currently no impact factor.

ISSN

2150-5349 (online)

Review
Bilirubin in coronary artery disease: Cytotoxic or protective?  
Nancy Gupta, Tavankit Singh, Rahul Chaudhary, Sushil K Garg, Gurprataap Singh Sandhu, Varun Mittal, Rahul Gupta, Roxana Bodin, Sachin Sule
World J Gastrointest Pharmacol Ther 7(4):469-476. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.469
Local ablative treatments for hepatocellular carcinoma: An updated review  
Antonio Facciorusso, Gaetano Serviddio, Nicola Muscatiello
World J Gastrointest Pharmacol Ther 7(4):477-489. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.477
Treatment of pregnant women with a diagnosis of inflammatory bowel disease  
Sule Poturoglu, Asli Ciftcibasi Ormeci, Ali Erkan Duman
World J Gastrointest Pharmacol Ther 7(4):490-502. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.490
Logical hypothesis: Low FODMAP diet to prevent diverticulitis  
Yoshiharu Uno, Jennifer C van Velkinburgh
World J Gastrointest Pharmacol Ther 7(4):503-512. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.503
Eosinophilic gastroenteritis: Approach to diagnosis and management  
Antoine Abou Rached, Weam El Hajj
World J Gastrointest Pharmacol Ther 7(4):513-523. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.513
Minireviews
How I treat my inflammatory bowel disease-patients with thiopurines?  
Berrie Meijer, Chris JJ Mulder, Adriaan A van Bodegraven, Nanne K H de Boer
World J Gastrointest Pharmacol Ther 7(4):524-530. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.524
Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?  
Mark Safe, Wei H Chan, Steven T Leach, Lee Sutton, Kei Lui, Usha Krishnan
World J Gastrointest Pharmacol Ther 7(4):531-539. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.531
Basic Study
A20 inhibits lipopolysaccharide-induced inflammation in enterocytes  
Cui-Fang Zheng, Jie-Ru Shi, Ying Huang, Sheng-Nan Wang
World J Gastrointest Pharmacol Ther 7(4):540-549. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.540
Retrospective Cohort Study
Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori  
Shinya Yamada, Takumi Kawakami, Yoshikazu Nakatsugawa, Takahiro Suzuki, Hideki Fujii, Naoya Tomatsuri, Hideki Nakamura, Hideki Sato, Yusuke Okuyama, Hiroyuki Kimura, Norimasa Yoshida
World J Gastrointest Pharmacol Ther 7(4):550-555. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.550
Observational Study
Family history and disease outcomes in patients with Crohn’s disease: A comparison between China and the United States  
Pei-Qi Wang, Jun Hu, Elie S Al Kazzi, Eboselume Akhuemonkhan, Min Zhi, Xiang Gao, Raquel Holand de Paula Pessoa, Sami Ghazaleh, Tuhina Cornelius, Suhel Abbas Sabunwala, Shadi Ghadermarzi, Kartikeya Tripathi, Mark Lazarev, Pin-Jin Hu, Susan Hutfless
World J Gastrointest Pharmacol Ther 7(4):556-563. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.556
Good adherence to mediterranean diet can prevent gastrointestinal symptoms: A survey from Southern Italy  
Francesco Paolo Zito, Barbara Polese, Letizia Vozzella, Antonietta Gala, Daniela Genovese, Viviana Verlezza, Fabiana Medugno, Antonello Santini, Luigi Barrea, Martina Cargiolli, Paolo Andreozzi, Giovanni Sarnelli, Rosario Cuomo
World J Gastrointest Pharmacol Ther 7(4):564-571. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.564
Randomized Clinical Trial
Efficacy of small-volume simethicone given at least 30 min before gastroscopy  
Mingjun Song, Andrew Boon Eu Kwek, Ngai Moh Law, Jeannie Peng Lan Ong, Jessica Yi-Lyn Tan, Prem Harichander Thurairajah, Daphne Shih Wen Ang, Tiing Leong Ang
World J Gastrointest Pharmacol Ther 7(4):572-578. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.572
Case Report
Osteonecrosis of both knees in a woman with Crohn's disease  
Mara Barbosa, José Cotter
World J Gastrointest Pharmacol Ther 7(4):579-583. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.579
Letters To The Editor
Gastroenterology, hepatology and movies: A holistic insight  
Guilherme Macedo, Marco Silva
World J Gastrointest Pharmacol Ther 7(4):584-586. Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.584